Business Context and Reporting Period
This Form 8-K was filed by Roman DBDR Tech Acquisition Corp. on December 15, 2021, under Item 8.01. The filing concerns its proposed business combination with CompoSecure Holdings, L.L.C. and supplements the definitive proxy statement for the special stockholder meeting scheduled for December 23, 2021. The provided request metadata identifies GPGI, Inc.; however, the filing text identifies Roman DBDR Tech Acquisition Corp. as the registrant.
Key Financial Metrics and Capitalization
- The filing does not report current-period revenue, profit, cash flow, margins, debt, liquidity, or other operating results.
- The January 2021 draft letter of intent contemplated a fully diluted post-transaction enterprise value of approximately $1.503 billion.
- The proposed transaction contemplated a PIPE investment of $200 million to $250 million and a minimum of $200 million of cash at closing, including PIPE proceeds.
- The filing does not provide updated transaction capitalization, PIPE commitments, cash balances, or financing terms.
Material Changes Versus Prior Comparable Period
- This filing does not present period-over-period financial comparisons.
- It voluntarily supplements the definitive proxy statement in response to shareholder litigation and demand letters, while stating that Roman DBDR denies liability or wrongdoing and does not concede that the additional disclosures were legally necessary or material.
- The supplemental disclosures expand the description of Roman DBDR’s target search, transaction negotiations, proposed transaction terms, and selection of financial and placement-agent advisers.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- Roman DBDR stated that it evaluated more than 100 potential acquisition targets and considered transaction structures for six targets, including CompoSecure.
- On June 23, 2021, a purported shareholder filed Lewis v. Roman DBDR Tech Acquisition Corp., et al. in New York state court challenging the proposed business combination. Roman DBDR also received demand letters from four purported shareholders seeking additional disclosures.
- Roman DBDR noted that additional lawsuits or demand letters could be filed or received. It issued the supplemental disclosures to avoid nuisance, cost, distraction, and potential delays to closing.
- The transaction remained subject to stockholder approval and other closing conditions. The filing does not confirm that the merger would close.
- Forward-looking risks include failure to complete the merger, failure to obtain required approvals, failure to satisfy closing conditions, transaction costs, inability to realize anticipated benefits, market acceptance of CompoSecure’s products, competition, market growth, and the ability to attract and retain clients.
- The filing contains no new operating guidance or confirmed financial forecast.
Important Facts for Investors to Verify
- Whether Roman DBDR stockholders approved the proposed CompoSecure transaction at or after the December 23, 2021 special meeting.
- The final transaction valuation, PIPE proceeds, minimum closing cash, redemption levels, and post-closing capitalization.
- The status and potential cost or impact of the Lewis litigation and related shareholder demands.
- The complete definitive proxy statement, supplemental disclosures, risk factors, and subsequent SEC filings.
- Whether the proposed merger closed and whether the anticipated strategic and financial benefits were realized.